NO20072190L - Fremgangsmater og sammensetninger for behandling av kronisk lymfatisk leukemi - Google Patents
Fremgangsmater og sammensetninger for behandling av kronisk lymfatisk leukemiInfo
- Publication number
- NO20072190L NO20072190L NO20072190A NO20072190A NO20072190L NO 20072190 L NO20072190 L NO 20072190L NO 20072190 A NO20072190 A NO 20072190A NO 20072190 A NO20072190 A NO 20072190A NO 20072190 L NO20072190 L NO 20072190L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- treatment
- methods
- lymphatic leukemia
- chronic lymphatic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62463804P | 2004-11-02 | 2004-11-02 | |
PCT/US2005/039816 WO2006050457A2 (en) | 2004-11-02 | 2005-11-02 | Methods and compositions for treating chronic lymphocytic leukemia |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072190L true NO20072190L (no) | 2007-07-13 |
Family
ID=36319809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072190A NO20072190L (no) | 2004-11-02 | 2007-04-27 | Fremgangsmater og sammensetninger for behandling av kronisk lymfatisk leukemi |
Country Status (13)
Country | Link |
---|---|
US (1) | US20080280878A1 (ru) |
EP (1) | EP1814392A4 (ru) |
JP (1) | JP2008519031A (ru) |
KR (1) | KR20070085677A (ru) |
CN (1) | CN101072504A (ru) |
AU (1) | AU2005302000A1 (ru) |
BR (1) | BRPI0517268A (ru) |
CA (1) | CA2584266A1 (ru) |
IL (1) | IL182618A0 (ru) |
MX (1) | MX2007004893A (ru) |
NO (1) | NO20072190L (ru) |
RU (1) | RU2007120473A (ru) |
WO (1) | WO2006050457A2 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006050373A2 (en) | 2004-11-02 | 2006-05-11 | The Regents Of The University Of California | Methods and compositions for modulating apoptosis |
PE20081506A1 (es) | 2006-12-12 | 2008-12-09 | Infinity Discovery Inc | Formulaciones de ansamicina |
CN101220068B (zh) * | 2008-01-18 | 2012-06-13 | 中国医学科学院医药生物技术研究所 | 一组格尔德霉素衍生物及其制备方法 |
US20110053873A1 (en) | 2008-02-01 | 2011-03-03 | Takeda Pharmaceutical Company Limited | Hsp90 inhibitors |
JP2012500013A (ja) * | 2008-08-18 | 2012-01-05 | マックス−プランク−ゲゼルシャフト ツール フェルデルンク デル ヴィッセンシャフテン エー.ファウ. | Hsp90阻害剤に対する感受性 |
CA2737493A1 (en) | 2008-09-17 | 2010-03-25 | Sphingomonas Research Partners, L.P. | Treatment for leukemia and idiopathic aplastic anemia |
DE102008061214A1 (de) * | 2008-12-09 | 2010-06-10 | Merck Patent Gmbh | Chinazolinamidderivate |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992021032A1 (en) * | 1991-05-24 | 1992-11-26 | The Regents Of The University Of California | Methods for the detection of bcr-abl and abnormal abl proteins in leukemia patients |
US6025126A (en) * | 1991-10-28 | 2000-02-15 | Arch Development Corporation | Methods and compositions for the detection of chromosomal aberrations |
US5932566A (en) * | 1994-06-16 | 1999-08-03 | Pfizer Inc. | Ansamycin derivatives as antioncogene and anticancer agents |
US6174875B1 (en) * | 1999-04-01 | 2001-01-16 | University Of Pittsburgh | Benzoquinoid ansamycins for the treatment of cardiac arrest and stroke |
EP1423080A4 (en) * | 2001-03-01 | 2009-06-03 | Conforma Therapeutics Corp | PROCESS FOR TREATING PROLIFERATIVE GENETIC DISORDERS WITH HSP90 INHIBITORS |
US6872715B2 (en) * | 2001-08-06 | 2005-03-29 | Kosan Biosciences, Inc. | Benzoquinone ansamycins |
CA2468202A1 (en) * | 2001-12-12 | 2003-06-19 | Conforma Therapeutics Corporation | Assays and implements for determining and modulating hsp90 binding activity |
US20030194409A1 (en) * | 2002-01-17 | 2003-10-16 | Rothman James E. | Conjugate heat shock protein-binding peptides |
US7465718B2 (en) * | 2002-02-08 | 2008-12-16 | Conforma Therapeutics Corporation | Ansamycins having improved pharmacological and biological properties |
US7329502B2 (en) * | 2002-04-25 | 2008-02-12 | The United States Of America As Represented By The Department Of Health And Human Services | ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) |
JP2006515883A (ja) * | 2003-01-10 | 2006-06-08 | スレッシュオールド ファーマシューティカルズ, インコーポレイテッド | 2−デオキシグルコースによる癌の処置 |
WO2005028434A2 (en) * | 2003-09-18 | 2005-03-31 | Conforma Therapeutics Corporation | Novel heterocyclic compounds as hsp90-inhibitors |
WO2005063714A1 (en) * | 2003-12-23 | 2005-07-14 | Infinity Pharmaceuticals, Inc | Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
-
2005
- 2005-11-02 KR KR1020077012496A patent/KR20070085677A/ko not_active Application Discontinuation
- 2005-11-02 JP JP2007540031A patent/JP2008519031A/ja active Pending
- 2005-11-02 CA CA002584266A patent/CA2584266A1/en not_active Abandoned
- 2005-11-02 RU RU2007120473/14A patent/RU2007120473A/ru not_active Application Discontinuation
- 2005-11-02 AU AU2005302000A patent/AU2005302000A1/en not_active Abandoned
- 2005-11-02 CN CNA2005800378584A patent/CN101072504A/zh active Pending
- 2005-11-02 WO PCT/US2005/039816 patent/WO2006050457A2/en active Application Filing
- 2005-11-02 MX MX2007004893A patent/MX2007004893A/es not_active Application Discontinuation
- 2005-11-02 EP EP05826502A patent/EP1814392A4/en not_active Withdrawn
- 2005-11-02 US US11/667,005 patent/US20080280878A1/en not_active Abandoned
- 2005-11-02 BR BRPI0517268-3A patent/BRPI0517268A/pt not_active IP Right Cessation
-
2007
- 2007-04-17 IL IL182618A patent/IL182618A0/en unknown
- 2007-04-27 NO NO20072190A patent/NO20072190L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2005302000A1 (en) | 2006-05-11 |
US20080280878A1 (en) | 2008-11-13 |
WO2006050457A3 (en) | 2006-12-14 |
CN101072504A (zh) | 2007-11-14 |
JP2008519031A (ja) | 2008-06-05 |
EP1814392A4 (en) | 2008-06-11 |
BRPI0517268A (pt) | 2008-10-07 |
EP1814392A2 (en) | 2007-08-08 |
CA2584266A1 (en) | 2006-05-11 |
MX2007004893A (es) | 2007-06-14 |
RU2007120473A (ru) | 2008-12-10 |
WO2006050457A2 (en) | 2006-05-11 |
KR20070085677A (ko) | 2007-08-27 |
IL182618A0 (en) | 2007-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072190L (no) | Fremgangsmater og sammensetninger for behandling av kronisk lymfatisk leukemi | |
DE602004006433D1 (de) | Pyrrol-substituierte indole als inhibitoren von pai-1 | |
NO20082305L (no) | Mikrobiologisk stabilisert ol | |
WO2004093826A3 (en) | Compositions of cyclooxygenase-2 selective inhibitors and 5-ht1b/1d agonists for the treatment and prevention of migraine | |
EA200900091A1 (ru) | Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний | |
ATE373655T1 (de) | 1-(heteroaryl-phenyl)-kondensierte pyrazol- derivate als factor xa inhibitoren | |
DK1789419T3 (da) | Gyraseinhibitorer og anvendelser deraf | |
TW200608961A (en) | Methods and reagents for the treatment of metabolic disorders | |
SG130189A1 (en) | Substituted indole-o-glucosides | |
NO20054359L (no) | Cykliske protein tyrosin kinase inhibitorer | |
EA200501928A1 (ru) | Пирролодигидроизохинолины как ингибиторы pde10 | |
DE602006010564D1 (de) | Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer | |
NO20072951L (no) | Behandling av et intestinalt adenom og/eller adenokarsinom ved hemming av Notch-reaksjonsveiaktivering | |
UA86042C2 (en) | Substituted indazole-o-glucosides | |
PL375900A1 (en) | Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer | |
TW200716622A (en) | Substituted piperidines | |
EA200800755A1 (ru) | Ikk ингибиторы, предназначенные для лечения эндометриоза | |
NO20062300L (no) | Fremgangsmater og reagenser for behandling av inflammatoriske forstyrelser | |
CL2008001057A1 (es) | Agente para el tratamiento de micosis producida por saprolegnia, achlya y/o aphanomyces en peces, el cual comprende al menos un fungicida seleccionado entre a) inhibidores de l a mitosis y division celular, b) inhiidores de la sintesis de ergosterol o, c) derivados de piridina, benzopiranona, carbonitrilo,quinolinas, entre otras. | |
TW200500361A (en) | Compositions, combinations, and methods for treating cardiovascular conditions and other associated conditions | |
WO2007013997A3 (en) | Inhibition of the raf/mek/p-erk pathway for treating cancer | |
HK1080119A1 (en) | Methods and apparatus for stress relief using multiple energy sources | |
TW200616639A (en) | Methods for treating a mammal before, during and after cardiac arrest | |
TW200507840A (en) | Method of treating multiple myeloma | |
MX2007002917A (es) | Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |